Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.9%

1 terminated out of 54 trials

Success Rate

92.9%

+6.3% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed with results

Key Signals

1 with results93% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (20)
P 1 (4)
P 2 (2)
P 4 (2)

Trial Status

Recruiting20
Completed13
Not Yet Recruiting12
Active Not Recruiting4
Enrolling By Invitation3
Unknown1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT07737665Phase 4RecruitingPrimary

Efficacy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bowel Disease Patients With Clinical Remission: A Randomized Double-Blind Placebo-Controlled Trial

NCT06773182Not ApplicableCompletedPrimary

Assessing Interventions of Diet in IBD

NCT07699926Not ApplicableCompleted

Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome

NCT07675369Not ApplicableCompletedPrimary

Nationwide Survey of Telemedicinal Patient Education in IBD

NCT07660289CompletedPrimary

Combined Advanced Targeted Therapy for Inflammatory Bowel Disease

NCT07644117RecruitingPrimary

Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

NCT07632573Phase 1Recruiting

A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

NCT07616791Phase 1CompletedPrimary

A Phase I Study of INT-210 Capsules in Healthy Adult Subjects (INT-210-I101)

NCT07289672Not ApplicableEnrolling By Invitation

Food Limitations In Crohn's Disease and Ulcerative coliTis

NCT07335705RecruitingPrimary

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

NCT07165470Not ApplicableRecruiting

Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease

NCT07353853Not ApplicableRecruitingPrimary

Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

NCT07314606Not ApplicableRecruiting

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

NCT07089420CompletedPrimary

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

NCT06839820Not ApplicableActive Not Recruiting

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

NCT07539077CompletedPrimary

Prevalence of Disorders of Gut-Brain-Interaction in Pediatric Patients With In-remission Inflammatory Bowel Disease

NCT07470502Not ApplicableRecruitingPrimary

MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

NCT07471490Enrolling By InvitationPrimary

Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.

NCT07444060Recruiting

Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

NCT07385807Not Yet Recruiting

Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease

Scroll to load more

Research Network

Activity Timeline